Inmune Bio INMB
NASDAQ INMB
$1.10 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Inmune Bio (INMB) Common Stock Issued (2018 - 2026)

Updated

Analysis

Inmune Bio (INMB) Common Stock Issued (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 743.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 247.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 87.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Inmune Bio 30.71 Mn -50.14 Mn - 1.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.33 Mn
Jun 30, 2025 22.27 Mn
Mar 31, 2025 5.27 Mn
Dec 31, 2024 422,000.00
Sep 30, 2024 12.29 Mn
Jun 30, 2022 699,000.00
Mar 31, 2022 30,000.00
Sep 30, 2021 1.14 Mn
Mar 31, 2021 18,000.00
Sep 30, 2020 23.24 Mn
Jun 30, 2020 664,000.00
Mar 31, 2020 1.00 Mn
Jun 30, 2019 4.96 Mn
Mar 31, 2019 7.25 Mn
Mar 31, 2018 900,000.00
API Access

Inmune Bio Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=INMB&period=max&api_key=YOUR_API_KEY